Search - tctmd.com

Displaying 541 - 560 of 1339

Sort: Relevancy | Date

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

Caitlin E. Cox

October 24, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

L.A. McKeown

October 15, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2019

Shelley Wood

October 01, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

Presentation TCT 2019

BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI

Presenter: Philippe Genereux

September 29, 2019

Presentation TCT 2019

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

Presenter: Antonio Colombo

September 28, 2019

Presentation TCT 2019

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

Presenter: Azeem Latib

September 28, 2019

Presentation TCT 2019

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

Presenter: Roxana Mehran

September 28, 2019

Presentation TCT 2019

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

The Role of Antiplatelet Agents in Patients With Diabetes and Coronary Disease

Presenter: Marc Bonaca

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

News Daily News

Greater Exposure to Toxins on 9/11 Left Firefighters at Increased Long-term CVD Risk

L.A. McKeown

September 11, 2019

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Caitlin E. Cox

September 06, 2019

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31997-X/fulltext

News Conference News ESC 2019

Ten-Year SYNTAXES Results Fix Roles for CABG, PCI in Complex CAD

Shelley Wood

September 05, 2019

News Conference News ESC 2019

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Yael L. Maxwell

September 01, 2019

Advertisement

Repeat Target-Lesion PCI: An Option for Public Reporting?

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

Recurrent Events Common Among Young Patients With CAD

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

TCTMD’s Top 10 Most Popular Stories for September 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

The Role of Antiplatelet Agents in Patients With Diabetes and Coronary Disease

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Greater Exposure to Toxins on 9/11 Left Firefighters at Increased Long-term CVD Risk

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Ten-Year SYNTAXES Results Fix Roles for CABG, PCI in Complex CAD

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content